Skip to Main Content

Author Details

Maria Aparecida Azevedo Koike Folgueira
Center for Translational Oncology, Cancer Institute of the State of Sao Paulo - ICESP
1993
51
19
PMIDPaper TitleJournal TitlePublished Year
35264596Detection of germline variants in Brazilian breast cancer patients using multigene panel testing.Sci Rep2022
35039532Value of the loss of heterozygosity to BRCA1 variant classification.NPJ Breast Cancer2022
32951185Analysis of RPL37A, MTSS1, and HTRA1 expression as potential markers for pathologic complete response and survival.Breast Cancer2021
34944094Somatic Mutational Profile of High-Grade Serous Ovarian Carcinoma and Triple-Negative Breast Carcinoma in Young and Elderly Patients: Similarities and Divergences.Cells2021
34567264Survival analysis of young adults from a Brazilian cohort of non-small cell lung cancer patients.Ecancermedicalscience2021
34287479Germline and Somatic mutations in postmenopausal breast cancer patients.Clinics (Sao Paulo)2021
30959822Transcriptomic Response to 1,25-Dihydroxyvitamin D in Human Fibroblasts with or without a Functional Vitamin D Receptor (VDR): Novel Target Genes and Insights into VDR Basal Transcriptional Activity.Cells2019
31817155Stromal Cell Signature Associated with Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer.Cells2019
30895400Frequency of CDH1 germline variants and contribution of dietary habits in early age onset gastric cancer patients in Brazil.Gastric Cancer2019
30281703Survival and prognosis of young adults with gastric cancer.Clinics (Sao Paulo)2018
30241261How Should Genetic Counseling for Ovarian Cancer Be Implemented in a Middle-Income Country? An Insight Based on the Brazilian Scenario.J Glob Oncol2018
29854292Somatic mutations in early onset luminal breast cancer.Oncotarget2018
30517521Cost effectiveness of the cancer prevention program for carriers of the BRCA1/2 mutation.Rev Saude Publica2018
30281704Clinical stage and histological type of the most common carcinomas diagnosed in young adults in a reference cancer hospital.Clinics (Sao Paulo)2018
28619461Predictability of BRCA1/2 mutation status in patients with ovarian cancer: How to select women for genetic testing in middle-income countries.Maturitas2017
28355358Breast-conserving surgery in locally advanced breast cancer submitted to neoadjuvant chemotherapy. Safety and effectiveness based on ipsilateral breast tumor recurrence and long-term follow-up.Clinics (Sao Paulo)2017
28492801Orthotopic tumorgrafts in nude mice as a model to evaluate calcitriol effects in breast cancer.Braz J Biol2017
27547399The role of oncoplastic breast conserving treatment for locally advanced breast tumors. A matching case-control study.Ann Med Surg (Lond)2016
27914478Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil.BMC Cancer2016
26248245Association of family risk and lifestyle/comorbidities in ovarian cancer patients.Rev Assoc Med Bras (1992)2015
26603012Somatic mutations in breast and serous ovarian cancer young patients: a systematic review and meta-analysis.Rev Assoc Med Bras (1992)2015
23623780Calcitriol supplementation effects on Ki67 expression and transcriptional profile of breast cancer specimens from post-menopausal patients.Clin Nutr2014
25249769Transcriptional profile of fibroblasts obtained from the primary site, lymph node and bone marrow of breast cancer patients.Genet Mol Biol2014
22939885Differences in transcriptional effects of 1α,25 dihydroxyvitamin D3 on fibroblasts associated to breast carcinomas and from paired normal breast tissues.J Steroid Biochem Mol Biol2013
24229053Markers of breast cancer stromal fibroblasts in the primary tumour site associated with lymph node metastasis: a systematic review including our case series.Biosci Rep2013
23636418Breast cancer tissue slices as a model for evaluation of response to rapamycin.Cell Tissue Res2013
23469205Comprehensive analysis of BRCA1, BRCA2 and TP53 germline mutation and tumor characterization: a portrait of early-onset breast cancer in Brazil.PLoS One2013
23497279Transcriptional effects of 1,25 dihydroxyvitamin D(3) physiological and supra-physiological concentrations in breast cancer organotypic culture.BMC Cancer2013
22858800Feasibility of oncoplastic techniques in the surgical management of locally advanced breast cancer.Int J Surg2012
20820980Influence of the interaction between nodal fibroblast and breast cancer cells on gene expression.Tumour Biol2011
21691702Transcriptional profile and response to neoadjuvante chemotherapy in breast cancer.Rev Assoc Med Bras (1992)2011
20307664Human breast tumor slices: a model for identification of vitamin D regulated genes in the tumor microenvironment.J Steroid Biochem Mol Biol2010
21103787Gene trio signatures as molecular markers to predict response to doxorubicin cyclophosphamide neoadjuvant chemotherapy in breast cancer patients.Braz J Med Biol Res2010
19530251Reciprocal changes in gene expression profiles of cocultured breast epithelial cells and primary fibroblasts.Int J Cancer2009
19893985Expression of E-cadherin, Snail and Hakai in epithelial cells isolated from the primary tumor and from peritumoral tissue of invasive ductal breast carcinomas.Braz J Med Biol Res2009
19724859Gene expression profile of residual breast cancer after doxorubicin and cyclophosphamide neoadjuvant chemotherapy.Oncol Rep2009
18601734Tumor slices as a model to evaluate doxorubicin in vitro treatment and expression of trios of genes PRSS11, MTSS1, CLPTM1 and PRSS11, MTSS1, SMYD2 in canine mammary gland cancer.Acta Vet Scand2008
19199269Expression of heterochromatin protein 1 in the primary tumor of breast cancer patients in the presence or absence of occult metastatic cells in the bone marrow.Int J Biol Markers2008
18534255Expression of vitamin D receptor mRNA in the hippocampal formation of rats submitted to a model of temporal lobe epilepsy induced by pilocarpine.Brain Res Bull2008
16906285Gene expression profiling of clinical stages II and III breast cancer.Braz J Med Biol Res2006
1682828325(OH)D3 and 1,25(OH)2D3 serum concentration and breast tissue expression of 1alpha-hydroxylase, 24-hydroxylase and Vitamin D receptor in women with and without breast cancer.J Steroid Biochem Mol Biol2006
16243817Gene expression profile associated with response to doxorubicin-based therapy in breast cancer.Clin Cancer Res2005
14652754Vitamin D3 modulation of plasminogen activator inhibitor type-1 in human breast carcinomas under organ culture.Virchows Arch2004
15544934Ras activation is associated with vitamin D receptor mRNA instability in HC11 mammary cells.J Steroid Biochem Mol Biol2004
12648525Molecular targets of 1,25(OH)2D3 in HC11 normal mouse mammary cell line.J Steroid Biochem Mol Biol2003
14666262Normal HC11 and ras-transformed mouse mammary cells are resistant to the antiproliferative effects of retinoic acid.Braz J Med Biol Res2003
11743608Antiproliferative effects of 1,25-dihydroxyvitamin D3 on breast cells: a mini review.Braz J Med Biol Res2002
10775888Differential regulation of vitamin D receptor expression in distinct leukemic cell lines upon phorbol ester-induced growth arrest.Braz J Med Biol Res2000
9744516Expression of vitamin D receptor (VDR) in HL-60 cells is differentially regulated during the process of differentiation induced by phorbol ester, retinoic acid or interferon-gamma.J Steroid Biochem Mol Biol1998
7679173Vitamin D3 binding activity during leukemic cell differentiation.Leuk Res1993
  • 1 - 50 of 51

Recommended Authors

University of Toronto
Career Start Year 2011
Number of shared co-authors 1
University of Genoa and Ospedale Policlinico San Martino
Career Start Year 2008
Number of shared co-authors 0
University of Turin, Candiolo Cancer Institute, FPO-IRCCS
Career Start Year 2005
Number of shared co-authors 2
Lund University
Career Start Year 2003
Number of shared co-authors 0
Otto-Friedrich-University Bamberg
Career Start Year 2002
Number of shared co-authors 2
Olivia Newton-John Cancer Research Institute
Career Start Year 2002
Number of shared co-authors 2
IEO European Institute of Oncology IRCCS
Career Start Year 2002
Number of shared co-authors 2
UCD Conway Institute, University College Dublin
Career Start Year 2001
Number of shared co-authors 0
Familial Cancer Clinic, Hospital Sant Pau
Career Start Year 2000
Number of shared co-authors 3
Lund University and Skane University Hospital
Career Start Year 1997
Number of shared co-authors 0
Karolinska Institutet
Career Start Year 1997
Number of shared co-authors 0
Memorial Sloan-Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 3
University Health Network
Career Start Year 1994
Number of shared co-authors 1
Westmead Institute for Medical Research, The University of Sydney
Career Start Year 1993
Number of shared co-authors 2
Radboud University Medical Center
Career Start Year 1993
Number of shared co-authors 1
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 2
University of Edinburgh
Career Start Year 1992
Number of shared co-authors 1
Fred Hutchinson Cancer Research Center
Career Start Year 1991
Number of shared co-authors 0
Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1991
Number of shared co-authors 0
Institutet of Bioinformatics, University Hospital of Munster, University of Munster
Career Start Year 1990
Number of shared co-authors 0
University Medical Center Utrecht
Career Start Year 1989
Number of shared co-authors 0
Erasmus Medical Center (MC) Cancer Institute
Career Start Year 1989
Number of shared co-authors 2
University of California San Francisco
Career Start Year 1984
Number of shared co-authors 2
Karolinska Institute
Career Start Year 1984
Number of shared co-authors 0
German Cancer Research Center (DKFZ)
Career Start Year 1984
Number of shared co-authors 3
University of Queensland
Career Start Year 1983
Number of shared co-authors 5
Faculty of Clinical Medicine, University of Oslo
Career Start Year 1983
Number of shared co-authors 2
Universidad de Alcala
Career Start Year 1983
Number of shared co-authors 1
Pathologisches Institut, Universitatsklinikum Heidelberg
Career Start Year 1981
Number of shared co-authors 1
University of Toronto
Career Start Year 1977
Number of shared co-authors 3

Collaborators

School of Medicine of Sao Paulo University
Co-authored papers 38
Sao Paulo University
Co-authored papers 34
Instituto do Cancer do Estado de Sao Paulo, Universidade de Sao Paulo
Co-authored papers 16
Brazilian Institute of Cancer Control (IBCC)
Co-authored papers 13
Instituto Brasileiro de Controle do Cancer
Co-authored papers 12
AC Camargo Cancer Center
Co-authored papers 9
Instituto do Cancer do Estado de Sao Paulo and Universidade de Sao Paulo
Co-authored papers 7
Faculdade de Medicina, Universidade de Sao Paulo
Co-authored papers 6
Sao Paulo University
Co-authored papers 5
Instituto do Cancer do Estado de Sao Paulo, Faculdade de Medicina de Sao Paulo
Co-authored papers 4
Instituto Brasileiro de Controle do Cancer
Co-authored papers 3
Co-authored papers 3
Hospital Alemao Oswaldo Cruz
Co-authored papers 3
Ludwig Institute for Cancer Research Ltd.
Co-authored papers 1
Co-authored papers 1
QIMR Berghofer Medical Research Institute
Co-authored papers 1
Instituto Do Cancer Do Estado de Sao Paulo
Co-authored papers 1
University of California los angeles
Co-authored papers 1
Ontario Institute for Cancer Research
Co-authored papers 1
Co-authored papers 1
Universidade Federal de Santa Maria
Co-authored papers 1
Co-authored papers 1
A.C.Camargo Cancer Center
Co-authored papers 1
University of Sao Paulo
Co-authored papers 1
Peter MacCallum Cancer Centre
Co-authored papers 1